Ognomy Sleep Raises $20M Series A

Ognomy Sleep Raises $20M Series A

Ognomy Sleep, based in Buffalo, New York, a virtual sleep medicine platform, has raised $20 million in a Series A financing round. The company provides a virtual-first platform that manages the sleep apnea care journey from testing to treatment for patients across the United States.

This round was led by Catalyst Investors, with participation from Blue Heron Capital. Additional participating investors include Impellent Ventures, LaunchNY, Excell, Upstate Biotech Ventures, and the University of Buffalo.

Ognomy plans to use the new capital to accelerate growth, expand its AI-enabled clinical platform, develop wearable device integrations, and strengthen strategic partnerships within the healthcare ecosystem.

Founded in 2019 by sleep medicine physician Daniel Rifkin, Ognomy Sleep is on a mission to eliminate untreated sleep apnea as a global health crisis through scalable, outcomes-driven, and patient-centered care. The company offers a scalable, virtual-first model that streamlines the diagnosis, treatment, and long-term management of sleep apnea.

Funding Details

Company Website: https://ognomy.com

Company: Ognomy Sleep

Raised: $20M

Round: Series A

Funding Date: June 30, 2026

Lead Investor: Catalyst Investors

Additional Investors: Blue Heron Capital, Impellent Ventures, LaunchNY, Excell, Upstate Biotech Ventures, University of Buffalo

Company Website: https://ognomy.com

Software Category: HealthTech